Cargando…
Inflamma-MicroRNAs in Alzheimer’s Disease: From Disease Pathogenesis to Therapeutic Potentials
Alzheimer’s disease (AD) is the most common cause of senile dementia. Although AD research has made important breakthroughs, the pathogenesis of this disease remains unclear, and specific AD diagnostic biomarkers and therapeutic strategies are still lacking. Recent studies have demonstrated that neu...
Autores principales: | Liang, Yuanyuan, Wang, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581643/ https://www.ncbi.nlm.nih.gov/pubmed/34776873 http://dx.doi.org/10.3389/fncel.2021.785433 |
Ejemplares similares
-
Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer’s Disease
por: Giuliani, Angelica, et al.
Publicado: (2021) -
The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease
por: Samadian, Mohammad, et al.
Publicado: (2021) -
MicroRNAs in Huntington’s Disease: Diagnostic Biomarkers or Therapeutic Agents?
por: Dong, Xiaoyu, et al.
Publicado: (2021) -
Circulating extracellular vesicle-containing microRNAs reveal potential pathogenesis of Alzheimer’s disease
por: Wang, Yi, et al.
Publicado: (2022) -
Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer’s disease
por: Noor Eddin, Ahmed, et al.
Publicado: (2023)